Although malignant transformation in a fibroadenoma is rare, high suspicion index in middle aged women with fibroadenoma and associated risk factors like strong family history and/or BRCA-1, BRCA-2 mutation is recommended [6-8]. This evidence concerns the gene BRCA2 and Fibroadenoma.